Balanced Intersystem Crossing in Iodinated Silicon-Fluoresceins Allows New Class of Red Shifted Theranostic Agents.
Sultan CetinZubeyir ElmazogluOsman KaramanHande GunduzGorkem GunbasSafacan KolemenPublished in: ACS medicinal chemistry letters (2021)
Iodination of the silicon-fluorescein core revealed a new class of highly cytotoxic, red-shifted and water-soluble photosensitizer (SF-I) which is also fairly emissive to serve as a theranostic agent. Singlet oxygen generation capacity of SF-I was evaluated chemically, and up to 45% singlet oxygen quantum yield was reported in aqueous solutions. SF-I was further tested in triple negative breast (MDA MB-231) and colon (HCT-116) cancer cell lines, which are known to have limited chemotherapy options as well as very poor prognosis. SF-I induced efficient singlet oxygen generation and consequent photocytotoxicity in both cell lines upon light irradiation with a negligible dark toxicity while allowing cell imaging at the same time. SF-I marks the first ever example of a silicon xanthene-based photosensitizer and holds a lot of promise as a small-molecule-based theranostic scaffold.
Keyphrases
- photodynamic therapy
- poor prognosis
- small molecule
- fluorescence imaging
- water soluble
- long non coding rna
- single cell
- high resolution
- energy transfer
- oxidative stress
- papillary thyroid
- diabetic rats
- squamous cell carcinoma
- deep learning
- cell cycle arrest
- machine learning
- mass spectrometry
- signaling pathway
- mesenchymal stem cells
- lymph node metastasis
- tissue engineering
- artificial intelligence
- pi k akt
- monte carlo